BridgeMD
New treatment option for Cardiometabolic Disease
Official title Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
ClinicalTrials.gov ID: NCT06585462
What this study is testing
What is AMG 513?
AMG 513 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for cardiometabolic disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The primary objective of this study is to assess the safety and tolerability of AMG 513 after single and multiple doses.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Participants in the study will be males and females 18 to 65 years of age at the time of signing the informed consent with a body mass index (BMI) of...
- Females enrolled must be of non-childbearing potential.
You likely can't join if
- History and/or clinical evidence of diabetes mellitus, including hemoglobin A1c ≥ 6.5% and/or a fasting glucose of ≥ 126 mg/dL (7 mmol/L) at...
- Triglycerides ≥ 5.65 mmol/L (i.e., 500 mg/dL) at screening.
The study team makes the final eligibility decision.
Where it's taking place
- Anaheim, California, United States
- Lake Forest, California, United States
- Oxnard, California, United States
- Aventura, Florida, United States
- Jacksonville, Florida, United States
- Miami, Florida, United States
- Union City, Georgia, United States
- Fargo, North Dakota, United States
- Austin, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Anaheim, California, United States; Lake Forest, California, United States; Oxnard, California, United States; Aventura, Florida, United States; Jacksonville, Florida, United States; Miami, Florida, United States and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.